An interventional study of Colorado Adult Joint Assessment Evaluation in Hemophilia A, sponsored by Bayer. Completed at 4 sites in United States. Open to male participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2015-12-03.
Sponsored by Bayer · Not applicable and Interventional
To obtain evidence of content validity and reliability of the Colorado Adult Joint Assessment Scale (CAJAS), a clinician-reported outcome (ClinRO) measure, as adapted for use in a population of adults with moderate to severe hemophilia A treated with coagulation factor VIII (FVIII) therapy as secondary prophylaxis or episodic treatment.
866 studies on the registry are indexed under Hemophilia A; 137 are open to participants now.
This study's enrollment of 30 is close to the median of 28 across 512 interventional studies indexed under Hemophilia A.
Browse Hemophilia A studies →Bayer is the lead sponsor of 1,643 studies on the registry; 57 are open to participants now.
Of its 209 completed or terminated interventional studies of FDA-regulated products, 129 (62%) have results posted.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Other: Colorado Adult Joint Assessment Evaluation
Physical evaluation of 6 joints, ankles, knees and elbows
Colorado Adult Joint Assessment Score (CAJAS)
Time frame: Up to 25 days
This study is completed, as verified in Dec 2015. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Bayer